AVDL250117P7500
- 0.10
- -0.22-68.75%
Avadel Pharmaceuticals Newsroom
Avadel Pharmaceuticals Price Target Cut to $21.00/Share From $25.00 by HC Wainwright & Co.
Piper Sandler Maintains Avadel Pharmaceuticals(AVDL.US) With Buy Rating, Cuts Target Price to $13
Piper Sandler Keeps Their Buy Rating on Avadel Pharmaceuticals (AVDL)
H.C. Wainwright Maintains Avadel Pharmaceuticals(AVDL.US) With Buy Rating, Cuts Target Price to $21
Avadel Pharmaceuticals Analyst Ratings
Analysts Conflicted on These Healthcare Names: Avadel Pharmaceuticals (AVDL) and ACADIA Pharmaceuticals (ACAD)
Needham Maintains Avadel Pharmaceuticals(AVDL.US) With Buy Rating, Cuts Target Price to $19
UBS Maintains Avadel Pharmaceuticals(AVDL.US) With Buy Rating, Cuts Target Price to $22
Craig-Hallum Maintains Avadel Pharmaceuticals(AVDL.US) With Buy Rating
Avadel Pharmaceuticals Analyst Ratings
H.C. Wainwright Maintains Avadel Pharmaceuticals(AVDL.US) With Buy Rating, Cuts Target Price to $25
Craig-Hallum Maintains Avadel Pharmaceuticals(AVDL.US) With Buy Rating
Avadel Pharmaceuticals Price Target Maintained With a $22.00/Share by Needham
Avadel Pharmaceuticals Analyst Ratings
Craig-Hallum Maintains Avadel Pharmaceuticals(AVDL.US) With Buy Rating
Avadel Pharmaceuticals Is Maintained at Outperform by Oppenheimer
H.C. Wainwright Maintains Avadel Pharmaceuticals(AVDL.US) With Buy Rating, Maintains Target Price $27
Craig-Hallum Maintains Avadel Pharmaceuticals(AVDL.US) With Buy Rating
Oppenheimer Maintains Avadel Pharmaceuticals(AVDL.US) With Buy Rating, Raises Target Price to $30
Avadel Pharmaceuticals Analyst Ratings